Topic: HPV

Read the 2022 instalment of the VCPs bi-annual research report “The State of Vaccine Confidence in the EU,” which monitors public attitudes to vaccines across the continent.

In this review article, examples of hesitancy regarding the measles–mumps–rubella (MMR), human papillomavirus (HPV), and COVID-19 vaccines are used to explore the multifaceted issues that fuel vaccine hesitancy. Each of these examples is part of a larger, more complex story.

In this journal article, we draw findings and insights from the VCP’s decade-long monitoring of media and social media and its related research efforts.

The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination.

This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on Lower Middle Income Countries and the significant barriers in the…

The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines,…

Dr. Abosede Lewu from Girlsaid Initiative describes his experience with HPV vaccine advocacy and…

Dr. Omolola Salako shares her experience with HPV vaccination in Nigeria.

Ishak Lawal from End Cervical Cancer Nigeria Initiative shares lessons learned from a HPV pilot demonstration in Nigeria.

Bassey Okposen from the National Primary Health Care Development Agency in Nigeria shares the process and the challenges being faced to…

Kouassi Seraphin, Oumar Toure, and Chris Morgan from Jhpiego share the impact the COVID-19 pandemic has…

Ngwegwe Bulula provides an overview of the HPV demonstration project and the progress made toward national introduction in Tanzania.